BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34784305)

  • 41. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
    Liang RB; Yang J; Zeng TS; Long H; Fu JH; Zhang LJ; Lin P; Wang X; Rong TH; Hou X; Yang HX
    Ann Surg Oncol; 2018 Oct; 25(11):3300-3307. PubMed ID: 30083835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between Contrast-Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-Small Cell Lung Cancer.
    Yang H; Fan HX; Song LH; Xie JC; Fan SF
    Oncol Res Treat; 2017; 40(9):516-522. PubMed ID: 28866685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
    Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
    J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2006 Jun; 81(6):1969-73; discussion 1973. PubMed ID: 16731115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occult lymph node metastasis in radiologic stage I non-small cell lung cancer: The role of endobronchial ultrasound.
    Kukhon FR; Lan X; Helgeson SA; Arunthari V; Fernandez-Bussy S; Patel NM
    Clin Respir J; 2021 Jun; 15(6):676-682. PubMed ID: 33630405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with non-small-cell lung cancer: a study of 2062 cases.
    Wang YX; Li BS; Huang W; Yi Y; Zhang J; Wang ZhT; Sun HF; Li HS; Wei YM
    Br J Radiol; 2015; 88(1056):20140288. PubMed ID: 26126020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Advances in Lymph Node Metastasis and the Modes of Lymph Node 
Dissection in Early Stage Non-small Cell Lung Caner].
    Ding N; Mao Y
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):359-63. PubMed ID: 27335297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
    Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
    PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
    Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
    Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
    Toomey D; Smyth G; Condron C; Kay E; Conroy R; Foley D; Hong C; Hogan B; Toner S; McCormick P; Broe P; Kelly C; Bouchier-Hayes D
    Cancer; 2001 Nov; 92(10):2648-57. PubMed ID: 11745200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
    Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
    Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Undetected lymph node metastases in presumed early stage NSCLC SABR patients.
    Cerra-Franco A; Diab K; Lautenschlaeger T
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):869-75. PubMed ID: 27279087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on the Correlation Factors of 13, 14 Groups Lymph Node Metastasis of 
Non-small Cell Lung Cancer].
    Zhang L; Jiya B; Wang Y; Han B; Guo Z
    Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):248-252. PubMed ID: 28442013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.